Novel quinolinequinone antitumor agents:: Structure-metabolism studies with NAD(P)H:quinone oxidoreductase (NQO1)

被引:34
作者
Fryatt, T
Goroski, DT
Nilson, ZD
Moody, CJ
Beall, HD [1 ]
机构
[1] Univ Montana, Dept Pharmaceut Sci, Missoula, MT 59812 USA
[2] Univ Exeter, Sch Chem, Exeter EX4 4QD, Devon, England
关键词
D O I
10.1016/S0960-894X(99)00369-8
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The effects of functional group changes on the metabolism of novel quinolinequinones by recombinant human NAD(P)H:quinone oxidoreductase (NQO1) are described. Overall, the quinolinequinones were much better substrates for NQO1 than analogous indolequinones, with compounds containing heterocyclic substituents at C-2 being among the best substrates. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2195 / 2198
页数:4
相关论文
共 23 条
[1]  
BANZET P, 1978, CANCER, V41, P1240, DOI 10.1002/1097-0142(197804)41:4<1240::AID-CNCR2820410404>3.0.CO
[2]  
2-J
[3]  
BEALL HD, 1994, CANCER RES, V54, P3196
[4]   Indolequinone antitumor agents:: Correlation between quinone structure, rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase, and in vitro cytotoxicity [J].
Beall, HD ;
Winski, S ;
Swann, E ;
Hudnott, AR ;
Cotterill, AS ;
O'Sullivan, N ;
Green, SJ ;
Bien, R ;
Siegel, D ;
Ross, D ;
Moody, CJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (24) :4755-4766
[5]   Role of NAD(P)H:quinone oxidoreductase (DT-diaphorase) in cytotoxicity and induction of DNA damage by streptonigrin [J].
Beall, HD ;
Liu, YF ;
Siegel, D ;
Bolton, EM ;
Gibson, NW ;
Ross, D .
BIOCHEMICAL PHARMACOLOGY, 1996, 51 (05) :645-652
[6]  
BEALL HD, 1995, MOL PHARMACOL, V48, P499
[7]  
Ernster L., 1967, METHODS ENZYMOLOGY, VVolume 10, P309, DOI [10.1016/0076-6879(67)10059-1, DOI 10.1016/0076-6879(67)10059-1]
[8]   COMBINATION CHEMOTHERAPY OF NON-HODGKIN LYMPHOMA [J].
FORCIER, RJ ;
MCINTYRE, OR ;
NISSEN, NI ;
PAJAK, TF ;
GLIDEWELL, O ;
HOLLAND, JF .
MEDICAL AND PEDIATRIC ONCOLOGY, 1978, 4 (04) :351-362
[9]  
HACKETHAL C, 1961, ANTIBIOT CHEMOTHER, V11, P178
[10]  
Harding MM, 1997, CURR MED CHEM, V4, P405